- Home
- DNTH vs ALX Comparison
DNTH vs ALX Comparison
Compare DNTH & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- ALX
- Stock Information
- Founded
- DNTH 2015
- ALX 1928
- Country
- DNTH United States
- ALX United States
- Employees
- DNTH N/A
- ALX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- DNTH Health Care
- ALX Real Estate
- Exchange
- DNTH Nasdaq
- ALX Nasdaq
- Market Cap
- DNTH 1.0B
- ALX 1.2B
- IPO Year
- DNTH N/A
- ALX N/A
- Fundamental
- Price
- DNTH $37.04
- ALX $241.99
- Analyst Decision
- DNTH Strong Buy
- ALX
- Analyst Count
- DNTH 9
- ALX 0
- Target Price
- DNTH $61.57
- ALX N/A
- AVG Volume (30 Days)
- DNTH 969.3K
- ALX 42.8K
- Earning Date
- DNTH 11-06-2025
- ALX 11-03-2025
- Dividend Yield
- DNTH N/A
- ALX 7.37%
- EPS Growth
- DNTH N/A
- ALX N/A
- EPS
- DNTH N/A
- ALX 7.28
- Revenue
- DNTH $4,854,000.00
- ALX $218,089,000.00
- Revenue This Year
- DNTH N/A
- ALX N/A
- Revenue Next Year
- DNTH N/A
- ALX N/A
- P/E Ratio
- DNTH N/A
- ALX $33.54
- Revenue Growth
- DNTH 17.87
- ALX N/A
- 52 Week Low
- DNTH $13.37
- ALX $184.76
- 52 Week High
- DNTH $38.59
- ALX $260.84
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- ALX 60.67
- Support Level
- DNTH $36.00
- ALX $232.45
- Resistance Level
- DNTH $24.81
- ALX $247.42
- Average True Range (ATR)
- DNTH 2.70
- ALX 5.41
- MACD
- DNTH 1.31
- ALX 1.89
- Stochastic Oscillator
- DNTH 90.18
- ALX 74.31
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.